Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
Harvard Business School
Medtronic
Baxter

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for D-Tryptophan

See Plans and Pricing

« Back to Dashboard

Drug Development Status for D-Tryptophan: Sponsors, patents, clinical trial progress

D-Tryptophan is an investigational drug.

There have been 13 clinical trials for D-Tryptophan. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2003.

The most common disease conditions in clinical trials are Breast Neoplasms, Adenocarcinoma, and Pancreatic Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), NewLink Genetics Corporation, and Southwest Oncology Group.

Recent Clinical Trials for D-Tryptophan
TitleSponsorPhase
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerNational Cancer Institute (NCI)Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerSouthwest Oncology GroupPhase 3
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerUniversity of Colorado, DenverPhase 2

See all D-Tryptophan clinical trials

Clinical Trial Summary for D-Tryptophan

Top disease conditions for D-Tryptophan
Top clinical trial sponsors for D-Tryptophan

See all D-Tryptophan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Mallinckrodt
Colorcon
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.